Diagnosis, period | No. patients | Median (IQR), d | p value |
---|---|---|---|
Pancreatic malignancies pre-HPB program | 19 | 43 (28–75) | < 0.001 |
Pancreatic malignancies post-HPB program | 71 | 11 (5–24) | |
Adenocarcinomas pre-HPB program | 14 | 48 (23–77) | < 0.001 |
Adenocarcinomas post-HPB program | 45 | 10 (4–23) |
HPB = hepatopancreatobiliary; IQR = Interquartile range.